Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
If you want not to miss ideas like this one,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
I think the stock have already bottom. What are your thoughts @HorizontalPriceLevelsTrading?
GustavoK
⋅
It seems so🤔
MPH_
⋅
Forgot about this one; sold it too soon. What caused that drop in January? Did they have some bad trial news? Is it fundamentally a good trade and/or investment? Catalysts coming up? Would be good for you to identify if there are additional reasons to get into this, aside from the support level existence. I do see possible gap areas that could allow a quick rise up, though, I think.
TRADING_as_a_BUSINESS
⋅
@MPH_, I'll do that in the future, thanks for the idea!